Corrigendum: PMCA-based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt-Jakob disease

Related Articles:

• Differentiating PD from MSA February 20, 2020   There is a lot of clinical and biological similarities between the neurodegenerative conditions of Parkinson’s and multiple systems atrophy (or MSA). Recently, however, researchers have published a report suggesting that these two conditions may be differentiated from each other using a technique analysing protein in the cerebrospinal fluid – the liquid surrounding the brain, that can be accessed via…
• PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt-Jakob Disease April 11, 2022 Front Aging Neurosci. 2022 Mar 25;14:848991. doi: 10.3389/fnagi.2022.848991. eCollection 2022.ABSTRACTSporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disorder caused by the conformational conversion of the prion protein (PrPC) into an abnormally folded form, named prion (or PrPSc). The combination of the polymorphism at codon 129 of the PrP gene (coding either methionine or valine) with the biochemical feature of the…
• PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt-Jakob Disease April 11, 2022 Front Aging Neurosci. 2022 Mar 25;14:848991. doi: 10.3389/fnagi.2022.848991. eCollection 2022.ABSTRACTSporadic Creutzfeldt-Jakob disease (sCJD) is a rare neurodegenerative disorder caused by the conformational conversion of the prion protein (PrPC) into an abnormally folded form, named prion (or PrPSc). The combination of the polymorphism at codon 129 of the PrP gene (coding either methionine or valine) with the biochemical feature of the…
• Corrigendum: PMCA-based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt-Jakob disease March 16, 2023 Front Aging Neurosci. 2023 Feb 27;15:1073356. doi: 10.3389/fnagi.2023.1073356. eCollection 2023.ABSTRACT[This corrects the article DOI: 10.3389/fnagi.2022.848991.].PMID:36923119 | PMC:PMC10010189 | DOI:10.3389/fnagi.2023.1073356
• Corrigendum: PMCA-based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt-Jakob disease March 16, 2023 Front Aging Neurosci. 2023 Feb 27;15:1073356. doi: 10.3389/fnagi.2023.1073356. eCollection 2023.ABSTRACT[This corrects the article DOI: 10.3389/fnagi.2022.848991.].PMID:36923119 | PMC:PMC10010189 | DOI:10.3389/fnagi.2023.1073356
• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• Downregulation of Plasma Membrane Ca2+ ATPase driven by tyrosine hydroxylase-Gal4 reduces Drosophila lifespan independently of effects in neurons March 22, 2023 Fly (Austin). 2023 Dec;17(1):2192457. doi: 10.1080/19336934.2023.2192457.ABSTRACTIn Drosophila melanogaster, several Gal4 drivers are used to direct gene/RNAi expression to different dopaminergic neuronal clusters. We previously developed a fly model of Parkinson's disease, in which dopaminergic neurons had elevated cytosolic Ca2+ due to the expression of a Plasma Membrane Ca2+ ATPase (PMCA) RNAi under the thyroxine hydroxylase (TH)-Gal4 driver. Surprisingly, TH-Gal4>PMCARNAi flies…
• Monthly Research Review – December 2021 December 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – November 2020 November 30, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Monthly research review – March 2022 March 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during March 2022. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Aβ and Tau Prions Causing Alzheimer's Disease November 18, 2022 Methods Mol Biol. 2023;2561:293-337. doi: 10.1007/978-1-0716-2655-9_16.ABSTRACTStudies show that patients with Alzheimer's disease (AD) have both Aβ and tau prions, and thus, AD is a double-prion disease. AD patients with the greatest longevity exhibited low levels of both Aβ and tau prions; tau prions were nearly absent in the brains of almost half of the patients who lived beyond 80 years…
• Aβ and Tau Prions Causing Alzheimer's Disease November 18, 2022 Methods Mol Biol. 2023;2561:293-337. doi: 10.1007/978-1-0716-2655-9_16.ABSTRACTStudies show that patients with Alzheimer's disease (AD) have both Aβ and tau prions, and thus, AD is a double-prion disease. AD patients with the greatest longevity exhibited low levels of both Aβ and tau prions; tau prions were nearly absent in the brains of almost half of the patients who lived beyond 80 years…
• Aβ and Tau Prions Causing Alzheimer's Disease November 18, 2022 Methods Mol Biol. 2023;2561:293-337. doi: 10.1007/978-1-0716-2655-9_16.ABSTRACTStudies show that patients with Alzheimer's disease (AD) have both Aβ and tau prions, and thus, AD is a double-prion disease. AD patients with the greatest longevity exhibited low levels of both Aβ and tau prions; tau prions were nearly absent in the brains of almost half of the patients who lived beyond 80 years…
• Aβ and Tau Prions Causing Alzheimer's Disease November 18, 2022 Methods Mol Biol. 2023;2561:293-337. doi: 10.1007/978-1-0716-2655-9_16.ABSTRACTStudies show that patients with Alzheimer's disease (AD) have both Aβ and tau prions, and thus, AD is a double-prion disease. AD patients with the greatest longevity exhibited low levels of both Aβ and tau prions; tau prions were nearly absent in the brains of almost half of the patients who lived beyond 80 years…
• Aβ and Tau Prions Causing Alzheimer's Disease November 18, 2022 Methods Mol Biol. 2023;2561:293-337. doi: 10.1007/978-1-0716-2655-9_16.ABSTRACTStudies show that patients with Alzheimer's disease (AD) have both Aβ and tau prions, and thus, AD is a double-prion disease. AD patients with the greatest longevity exhibited low levels of both Aβ and tau prions; tau prions were nearly absent in the brains of almost half of the patients who lived beyond 80 years…
• Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder April 15, 2021 Brain. 2021 Apr 14:awab005. doi: 10.1093/brain/awab005. Online ahead of print.ABSTRACTIsolated REM sleep behaviour disorder (RBD) is an early-stage α-synucleinopathy in most, if not all, affected subjects. Detection of pathological α-synuclein in peripheral tissues of patients with isolated RBD may identify those progressing to Parkinson's disease, dementia with Lewy bodies or multiple system atrophy, with the ultimate goal of testing preventive…
• Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder April 15, 2021 Brain. 2021 Apr 14:awab005. doi: 10.1093/brain/awab005. Online ahead of print.ABSTRACTIsolated REM sleep behaviour disorder (RBD) is an early-stage α-synucleinopathy in most, if not all, affected subjects. Detection of pathological α-synuclein in peripheral tissues of patients with isolated RBD may identify those progressing to Parkinson's disease, dementia with Lewy bodies or multiple system atrophy, with the ultimate goal of testing preventive…
• Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder April 15, 2021 Brain. 2021 Apr 14:awab005. doi: 10.1093/brain/awab005. Online ahead of print.ABSTRACTIsolated REM sleep behaviour disorder (RBD) is an early-stage α-synucleinopathy in most, if not all, affected subjects. Detection of pathological α-synuclein in peripheral tissues of patients with isolated RBD may identify those progressing to Parkinson's disease, dementia with Lewy bodies or multiple system atrophy, with the ultimate goal of testing preventive…
• Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder April 15, 2021 Brain. 2021 Apr 14:awab005. doi: 10.1093/brain/awab005. Online ahead of print.ABSTRACTIsolated REM sleep behaviour disorder (RBD) is an early-stage α-synucleinopathy in most, if not all, affected subjects. Detection of pathological α-synuclein in peripheral tissues of patients with isolated RBD may identify those progressing to Parkinson's disease, dementia with Lewy bodies or multiple system atrophy, with the ultimate goal of testing preventive…
• Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder April 15, 2021 Brain. 2021 Apr 14:awab005. doi: 10.1093/brain/awab005. Online ahead of print.ABSTRACTIsolated REM sleep behaviour disorder (RBD) is an early-stage α-synucleinopathy in most, if not all, affected subjects. Detection of pathological α-synuclein in peripheral tissues of patients with isolated RBD may identify those progressing to Parkinson's disease, dementia with Lewy bodies or multiple system atrophy, with the ultimate goal of testing preventive…
• Monthly Research Review: January 2022 January 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…